MIRA INFORM REPORT

 

 

Report Date :

11.12.2013

 

IDENTIFICATION DETAILS

 

Name :

GENERON IGS INC

 

 

Registered Office :

16250 State Highway 249, Houston, TX 77086-1014

 

 

Country :

United States 

 

 

Year of Establishments:

1989

 

 

Legal Form :

Private Independent Company

 

 

Line of Business :

manufacturer of medical, surgical, ophthalmic, veterinary instruments and apparatus.

 

 

No. of Employees :

150

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

Slow but Correct  

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

United States 

A1

A1

 

Risk Category

ECGC Classification

 

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

united StaTes ECONOMIC OVERVIEW

 

The US has the largest and most technologically powerful economy in the world, with a per capita GDP of $49,800. In this market-oriented economy, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, they face higher barriers to enter their rivals' home markets than foreign firms face entering US markets. US firms are at or near the forefront in technological advances, especially in computers and in medical, aerospace, and military equipment; their advantage has narrowed since the end of World War II. The onrush of technology largely explains the gradual development of a "two-tier labor market" in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income. Imported oil accounts for nearly 55% of US consumption. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the United States into a recession by mid-2008. GDP contracted until the third quarter of 2009, making this the deepest and longest downturn since the Great Depression. To help stabilize financial markets, in October 2008 the US Congress established a $700 billion Troubled Asset Relief Program (TARP). The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009 the US Congress passed and President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012 the federal government reduced the growth of spending and the deficit shrank to 7.6% of GDP. Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through 2011, the direct costs of the wars totaled nearly $900 billion, according to US government figures. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries. In March 2010, President OBAMA signed into law the Patient Protection and Affordable Care Act, a health insurance reform that will extend coverage to an additional 32 million American citizens by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on health care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight. In December 2012, the Federal Reserve Board announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short term rates near zero until unemployment drops to 6.5% from the December rate of 7.8%, or until inflation rises above 2.5%. Long-term problems include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits - including significant budget shortages for state governments.

 

Source : CIA

 

Company name & address

 

Generon Igs Inc

16250 State Highway 249

Houston, TX 77086-1014

United States

Tel:                  713-937-5200

Fax:                 713-937-5250

Toll Free:           800-871-0310

Web:                 www.igs-global.com

 

company summary

 

Employees:                  150

Company Type:            Private Independent

Incorporation Date:         1989

Financials in:                 USD (Millions)

Reporting Currency:       US Dollar

Annual Sales:               20.3

Total Assets:                NA

 

 

Business Description     

 

Establishments primarily engaged in manufacturing medical, surgical, ophthalmic, veterinary instruments and apparatus.

 

Industry             

Industry            Medical Equipment and Supplies

ANZSIC 2006:    2412 - Medical and Surgical Equipment Manufacturing

ISIC Rev 4:        3250 - Manufacture of medical and dental instruments and supplies

NACE Rev 2:     3250 - Manufacture of medical and dental instruments and supplies

NAICS 2012:     339112 - Surgical and Medical Instrument Manufacturing

UK SIC 2007:    3250 - Manufacture of medical and dental instruments and supplies

US SIC 1987:    3841 - Surgical and Medical Instruments and Apparatus

 

           

Key Executives

(Emails Available)       

 

Name

Title

Tom Jeffers

Owner, Marketing Executive, Sales Executive

Ej Devine

Finance Executive, Human Resources Executive

Dave Brown

IT Executive, Telecommunications Executive

Leonard Piercy

Purchasing Agent

Tim Purcell

Engineering/Technical

 

1 - Profit & Loss Item Exchange Rate: USD 1 = USD 1

2 - Balance Sheet Item Exchange Rate: USD 1 = USD 1

 

 

Corporate Overview

 

Location

16250 State Highway 249

Houston, TX, 77086-1014

Harris County

United States

Tel:                   713-937-5200

Fax:                  713-937-5250

Toll Free Tel:     800-871-0310

Web:                www.igs-global.com

           

Sales USD(mil):             20.3

Assets USD(mil):           NA

Employees:                   150

Industry:                        Medical Equipment and Supplies

Incorporation Date:         1989

Company Type:             Private Independent

Quoted Status:              Not Quoted

 

Owner, Marketing Executive, Sales Executive:

Tom Jeffers

 

Industry Codes

 

ANZSIC 2006 Codes:

2412     -          Medical and Surgical Equipment Manufacturing

3323     -          Industrial and Agricultural Chemical Product Wholesaling

 

ISIC Rev 4 Codes:

3250     -          Manufacture of medical and dental instruments and supplies

4669     -          Wholesale of waste and scrap and other products n.e.c.

 

NACE Rev 2 Codes:

3250     -          Manufacture of medical and dental instruments and supplies

4675     -          Wholesale of chemical products

 

NAICS 2012 Codes:

339112  -          Surgical and Medical Instrument Manufacturing

424690  -          Other Chemical and Allied Products Merchant Wholesalers

 

US SIC 1987:

3841     -          Surgical and Medical Instruments and Apparatus

5169     -          Chemicals and Allied Products, Not Elsewhere Classified

 

UK SIC 2007:

3250     -          Manufacture of medical and dental instruments and supplies

4675     -          Wholesale of chemical products

 

Business Description

Establishments primarily engaged in manufacturing medical, surgical, ophthalmic, veterinary instruments and apparatus.

 

Product Codes

Product Code

Product Description

MAN-CH

Hollow fiber membrane module separation machines

MAN-CH

Pressure swing adsorption machines

SUB-ES-GF

Gas generators

 

Financial Data

Financials in:

USD(mil)

 

Revenue:

20.3

1 Year Growth

NA

 

Additional Information

ABI Number:

491822722

 

 

Credit Report as of 04/01/2013

 

Location

16250 State Highway 249
Houston, TX 77086-1014
United States

 

County:

Harris

MSA:

Houston, TX

 

Phone:

713-937-5200

Fax:

713-937-5250

Toll Free:

800-871-0310

URL:

http://igs-global.com

 

ABI©:

491822722

 

Annual Sales:

$20,280,000 (USD)

Employees:

150

 

Facility Size(ft2):

40,000+

Facility Own/Lease:

Lease

 

Business Type:

Private

Location Type:

Single Location

Primary Line of Business:

SIC:

3841-04 - Physicians & Surgeons Equip & Supls-Mfrs

NAICS:

339112 - Surgical & Medical Instrument Mfg

Secondary Lines of Business:

NAICS:

424690 - Other Chemical Merchant Whols

SICs:

5169-50 - Nitrogen (Whls)

 

9999-66 - Federal Government Contractors

 

 

Executive report

 

Executives

 

Name

Title

Function

 

Tom Jeffers

 

Owner, Marketing Executive, Sales Executive

Owner/Proprietor

 

Ej Devine

l

Finance Executive, Human Resources Executive

Finance Executive

 

Dave Brown

 

IT Executive, Telecommunications Executive

Engineering/Technical Executive

 

Tim Purcell

 

Engineering/Technical

Engineering/Technical Executive

 

Leonard Piercy

 

Purchasing Agent

Purchasing Executive

 

 

Generon Sends Nitrogen Membrane System To Middle East

 

Compressor Tech 2

5 September, 2013

Generon IGS is shipping an integrated skidded nitrogen membrane system with duplex primary oil-free air compression and an air dryer to the Middle East. The system will be used for the West Qurna Second Field Phase Project. The system, which meets PED and CE

 

 

Generon IGS Ships Nitrogen Generator to Middle East for Inerting of Process Gas

 

Manufacturing Digital

 

5 September, 2013

Houston-based air separation membrane technology supplier Generon IGS ships large Integrated Skidded Nitrogen Membrane System with Duplex Primary Oil Free Air Compression and Air Dryer to the Middle East. This system will be used for the West Qurna Second .

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.21

UK Pound

1

Rs.100.65

Euro

1

Rs.84.15

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.